BE899717A - Procede de traitement antiarythmique de classe iii. - Google Patents

Procede de traitement antiarythmique de classe iii.

Info

Publication number
BE899717A
BE899717A BE0/212979A BE212979A BE899717A BE 899717 A BE899717 A BE 899717A BE 0/212979 A BE0/212979 A BE 0/212979A BE 212979 A BE212979 A BE 212979A BE 899717 A BE899717 A BE 899717A
Authority
BE
Belgium
Prior art keywords
antiarrhythmic
antiarythmic
treatment process
class iii
sotalol
Prior art date
Application number
BE0/212979A
Other languages
English (en)
Inventor
A Simon
J A Thomis
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23976573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE899717(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE899717A publication Critical patent/BE899717A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Light Receiving Elements (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Procédé antiarythmique, suivant lequel on administre une dose antiarythmique efficace mais non toxique de d-sotalol en substance sans 1-sotalol ou d'un sel d'addition d'acide pharmaceutiquement acceptable de celui-di à un mammifère faisant de l'arythmie ou susceptible d'en faire, afin d'augmenter la durée du potentiel d'action des cellules cardiaques suffisamment pour produire un effet antiarythmique en substance sans blocage des sites récepteurs Beta-adrénergiques. L'administration orale est préférée.
BE0/212979A 1983-05-23 1984-05-22 Procede de traitement antiarythmique de classe iii. BE899717A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49736883A 1983-05-23 1983-05-23

Publications (1)

Publication Number Publication Date
BE899717A true BE899717A (fr) 1984-11-22

Family

ID=23976573

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212979A BE899717A (fr) 1983-05-23 1984-05-22 Procede de traitement antiarythmique de classe iii.

Country Status (21)

Country Link
EP (1) EP0127435B1 (fr)
JP (1) JPS59222411A (fr)
AT (2) ATE66603T1 (fr)
BE (1) BE899717A (fr)
CA (1) CA1237079A (fr)
CH (1) CH662055A5 (fr)
CY (1) CY1552A (fr)
DE (2) DE3419067A1 (fr)
DK (1) DK161363C (fr)
FI (1) FI842041A7 (fr)
FR (1) FR2548898B1 (fr)
GB (1) GB2141339B (fr)
HK (1) HK74891A (fr)
IT (1) IT1209547B (fr)
LU (1) LU85371A1 (fr)
MY (1) MY100562A (fr)
NL (1) NL8401644A (fr)
NZ (1) NZ208229A (fr)
SE (1) SE468035B (fr)
SG (1) SG41290G (fr)
ZA (1) ZA843871B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69500377T2 (de) 1994-08-19 1997-10-09 Mitsui Toatsu Chemicals Pyrimidin-Dion-Derivate und diese enthaltende antiarrhythmische Zusammensetzungen
PT802900E (pt) * 1995-01-10 2000-07-31 Upjohn Co Enantiomeros s de metanossulfonamidas anti-arritmicos
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US334158A (en) * 1886-01-12 Geoege w
FR148F (fr) * 1962-01-24

Also Published As

Publication number Publication date
FI842041L (fi) 1984-11-24
GB2141339B (en) 1987-08-26
FR2548898B1 (fr) 1987-05-15
ZA843871B (en) 1985-01-30
SG41290G (en) 1990-08-03
EP0127435B1 (fr) 1991-08-28
GB8413217D0 (en) 1984-06-27
IT1209547B (it) 1989-08-30
SE468035B (sv) 1992-10-26
DE3419067A1 (de) 1984-11-29
SE8402756L (sv) 1984-11-24
CY1552A (en) 1991-03-22
EP0127435A2 (fr) 1984-12-05
SE8402756D0 (sv) 1984-05-22
EP0127435A3 (en) 1986-07-30
HK74891A (en) 1991-09-27
LU85371A1 (fr) 1985-03-21
DK251784A (da) 1984-11-24
JPS59222411A (ja) 1984-12-14
IT8421046A0 (it) 1984-05-22
ATA170584A (de) 1987-12-15
ATE66603T1 (de) 1991-09-15
AT386121B (de) 1988-07-11
DK161363B (da) 1991-07-01
NZ208229A (en) 1988-02-12
JPH0377172B2 (fr) 1991-12-09
DK251784D0 (da) 1984-05-22
MY100562A (en) 1990-11-15
CH662055A5 (de) 1987-09-15
FR2548898A1 (fr) 1985-01-18
CA1237079A (fr) 1988-05-24
NL8401644A (nl) 1984-12-17
DE3419067C2 (fr) 1989-09-21
FI842041A0 (fi) 1984-05-22
DE3484971D1 (de) 1991-10-02
GB2141339A (en) 1984-12-19
DK161363C (da) 1991-12-09
FI842041A7 (fi) 1984-11-24

Similar Documents

Publication Publication Date Title
Lucchesi et al. THE INFLUENCE OF DICHLOROISOPROTHERENOL (DCI) AND RELATED COMPOUNDS UPON OUABAIN AND ACETYLSTROPHANTHIDIN INDUCED CARDIAC ARRHYTHMIAS
Jones et al. Effects of radiations on the heart
Pincus Diphenylhydantoin and ion flux in lobster nerve
DE69022678T2 (de) S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
Chazov et al. Taurine and electrical activity of the heart
Wilson et al. Some muscular manifestations of hypothyroidism
LU84486A1 (fr) Nouveau derive de l'acide 2-(p-isobutylphenyl)propionique,son procede de preparation et son application en therapeutique
FI842760A0 (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi
BE898749A (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
Jacklet et al. Nerve regeneration: correlation of electrical, histological, and behavioral events
Hundley et al. The electrocardiogram in chronic thiamine deficiency in rats
Browne et al. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias
BE899717A (fr) Procede de traitement antiarythmique de classe iii.
Inoue et al. Characteristics of neuro‐effector transmission in the smooth muscle layer of dog bronchiole and modifications by autacoids.
FR2472561B1 (fr) Derives de l'acide 4-guanidinomethylcyclohexane carboxylique, leur procede de preparation et leur application en therapeutique
Zeft et al. Termination of paroxysmal junctional tachycardia by right ventricular stimulation
Mangla et al. Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats
Leiros et al. Potential role of mononuclear cells infiltration on the autoimmune myocardial dysfunction
EP0663819A1 (fr) Association d'ibuprofene et de cafeine
Mascitelli-Coriandoli et al. Cardiac damage caused by experimental stress
Graboys et al. Does coronary revascularization reduce the prevalence of ventricular ectopic activity?
FR2547814B1 (fr) Derives de l'acide bicyclo (3.2.1.) octane carboxylique, leur procede de preparation et leur application therapeutique
OA07978A (fr) Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon.
US4537907A (en) Hypnotic composition and method of inducing sleep
FR2534913B1 (fr) Acide (dimethyl-2,6 diethoxycarbonyl-3,5 dihydro-1,4 pyridine carboxamido-4)-2 glutarique et son sel disodique, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BRISTOL-MYERS CY

Effective date: 20040522